NCT02438319 (Planimetry) is a clinical trial of manual planimetry in Open Angle Glaucoma, sponsored by University of Zurich.

Who is sponsoring NCT02438319?

NCT02438319 is sponsored by University of Zurich.

What drugs are being tested in NCT02438319?

Interventions in NCT02438319: manual planimetry, automated planimetry.

What condition does NCT02438319 study?

NCT02438319 studies Open Angle Glaucoma.

Is NCT02438319 still recruiting?

NCT02438319 is currently withdrawn. Last updated 26 March 2020.

Last reviewed 2020-03-26 · How we verify

NCT02438319: Planimetry

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automatic vs. Manual Optic Disc Planimetry

Withdrawn Last updated 26 March 2020

What this trial tests

trial testing manual planimetry in Open Angle Glaucoma. Withdrawn.

Timeline

1 July 2017

Primary endpoint
20 March 2020

20 March 2020

Quick facts

Lead sponsor	University of Zurich
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	1 July 2017
Primary completion	20 March 2020
Estimated completion	20 March 2020

Drugs / interventions tested

manual planimetry
automated planimetry

Conditions studied

Open Angle Glaucoma — all drugs for Open Angle Glaucoma →

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Open Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Manually and automatically by mashing learning algorithm optic disc will be evaluated (planimetry).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Open Angle Glaucoma

Currently open trials in the same condition.

NCT07228221 — Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma · Phase 4 · recruiting
NCT06883123 — Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost · Phase 4 · recruiting
NCT06666855 — A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China · Phase 3 · active not recruiting
NCT06246136 — Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery · NA · recruiting
NCT06061718 — Travoprost Intraocular Implant in Conjunction With Cataract Surgery · Phase 3 · active not recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02438319 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 26 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02438319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing